CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 40 enrolled
Drug / intervention
Furosemidedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00478543
NCT00478543Phase 4Completed
CompareCT.gov

Effect of Loop Diuretics Treatment on Blood Pressure Control in Phase 3-4 of Chronic Kidney Disease

University of Campania Luigi Vanvitelli·interventional·Posted May 25, 2007·Updated Feb 4, 2009

In Brief

A Phase 4 clinical trial evaluating Furosemide for Chronic Kidney Disease. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of this study is to verify the efficacy of diuretic therapy on blood pressure control and left ventricular mass in patients affected by chronic kidney disease

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Kidney Disease
CountriesItaly
Collaborators--

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 25, 2007
Enrollment StartSep 1, 2005
Primary CompletionMay 1, 2008
Study CompletionJul 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 19.1 years ago

Interventions

Furosemidedrug